It is time for India to capitalize now on our unique strengths and overcome any
hurdles to ensure success in the bio-pharmaceutical market.” This was stated by
the Union Minister for Science& Technology and Earth Sciences, Environment,
Forests & Climate Change, Dr. Harshvardhan while addressing the media in
New Delhi today.
The first ever Industry-Academia mission to accelerate biopharmaceutical development in
India has been approved by the Government of India. The program named Innovate
in India (i3) will witness an investment of USD 250 million with USD 125
million as a loan from World Bank and aspires to create an enabling ecosystem
to promote entrepreneurship and indigenous manufacturing in the sector.